Non-neoformans cryptococcal infections: A systematic review

Infection

Volumn 35, Issue 2, 2007, Pages 51-58

  Khawcharoenporn, T ^a   Apisarnthanarak, A ^a   Mundy, L M ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

AGE DISTRIBUTION; ANTIFUNGAL ACTIVITY; BLOOD FLOW; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS ALBIDUS; CRYPTOCOCCUS LAURENTII; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG SENSITIVITY; EMPYEMA; FUNGAL VIRULENCE; FUNGEMIA; FUNGUS TRANSMISSION; HUMAN; IMMUNITY; LUNG ABSCESS; LUNG INFECTION; MENINGITIS; MORTALITY; MYCOSIS; PERITONITIS; PNEUMONIA; REVIEW; RISK FACTOR; SKIN INFECTION; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

AMPHOTERICIN B; CRYPTOCOCCOSIS; DRUG RESISTANCE, FUNGAL; HUMANS; RISK FACTORS;

EID: 34047221971     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6142-8     Document Type: Review

References (64)

1. Apisarnthanarak A, Powderly WG: Treatment of acute cryptococcal disease. Expert Opin Pharmacother 2001; 2: 1259-1268.
2. Kordossis T, Avlami A, Velegraki A, Stefanou I, Georgakopoulos G, Papalambrou C, Legakis NJ: First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol 1998; 36: 335-339.
3. McCurdy LH, Morrow JD: Infections due to non-neoformans cryptococcal species. Compr Ther 2003; 29: 95-101.
4. Johnson LB, Bradley SF, Kauffman CA: Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses 1998; 41: 277-280.
5. Khawcharoenporn T, Apisarnthanarak A, Kiratisin P, Mundy LM, Bailey TC: Evaluation of a possible case of Cryptococcus laurentii meningitis in a patient with HIV infection: a case report and review of the literature. Hawaii Med J 2006; 65: 260-263.
6. Bauters TG, Swinne D, Boekhout T, Noens L, Nelis HJ: Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient. Mycopathologia 2002; 153: 133-135.
7. Binder L, Csillag A, Toth G: Diffuse infiltration of the lungs associated with Cryptocococcus luteolus. Lancet 1956; 270: 1043-1045.
8. Tashima M, Sugita T, Shinoda T, Nakase: T Three new combinations from the Cryptococcus laurentii complex: Cryptococcus aureus, Cryptococcus carnescens and Cryptococcus peneaus. Int J Syst Evol Microbiol 2003; 53: 1187-1194.
9. Krcmery V Jr, Kunova A, Mardiak: J Nosocomial Cryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole. Infection 1997; 25: 130.
10. Wang CY, Wu HD, Hsueh PR: Nosocomial transmission of cryptococcosis. N Engl J Med 2005; 352: 1271-1272.
11. Sirinavin S, Intusoma U, Tuntirungsee S: Mother-to-child transmission of cryptococcus neoformans. Pediatr Infect Dis J 2004; 23: 278-279.
12. Harrison T: S Cryptococcus neoformans and cryptococcosis. J Infect 2000; 41: 12-17.
13. Perfect JR, Casadevall A: Cryptococcosis. Infect Dis Clin North Am 2002; 16: 837-874.
14. Ikeda R, Sugita T, Jacobson ES, Shinoda T Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans. J Clin Microbiol 2002; 40: 1214-1218.
15. Segal E, Baum GL Epidemiology, pathogenesis, immunopathogenesis and clinical manifestations of cryptococcosis. In: Baum GL, Segal E (eds) Pathogenic yeasts and yeast infections. CRC Press, Florida, pp 1994; 205-217.
16. Perfect JR: Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases. Churchill Livingstone, New York 2005, pp 2997-3009.
17. Zimmerman LE, Rappaport H: Occurrence of cryptococcosis in patients with malignant disease of reticuloendothelial system. Am J Clin Pathol 1954; 24: 1050.
18. Iseki M, Anzo M, Yamashita N, Matsuo N: Hyper-IgM immunodeficiency with disseminated cryptococcosis. Acta Paediatr 1994; 83: 780-782.
19. Husain A, Wagener MM, Singh N: Cryptococcus neoformans infection in organ transplant recipient: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 32: 145-150.
20. Tabone MD, Leverger G, Landman J, Asnar C, Boccon-Gibod L, Lasfargues G: Disseminated lymphonodular cryptococcosis in a child with x-linked hyper-IgM immunodeficiency. Pediatr Infect Dis J 1994; 13: 77-79.
21. Dev D, Basran GS, Slater D Consider: HIV negative immunodeficiency in cryptococcosis. BMJ 1994; 308: 1436.
22. da Cunha T, Lusins J: Cryptococcus albidus meningitis. South Med J 1973; 66: 1230.
23. Vlchkova-Lashkoska M, Kamberova S, Starova A, Goleva-Mishevska L, Tsatsa-Biljanovska N, Janevska V, Petrovska M: Cutaneous Cryptococcus laurentii infection in a human immunodeficiency virus-negative subject. J Eur Acad Dermatol Venereol 2004; 18: 99-100.
24. Loison J, Bouchara JP, Gueho E, de Gentile L, Cimon B, Chennebault JM, Chabasse D: First report of Cryptococcus albidus septicaemia in an HIV patient. J Infect 1996; 33: 139-140.
25. Shinde SM, Vanarse KS, Pandit AN: Systemic humicolus cryptococcosis. Indian Pediatr 2004; 41: 1162-1164.
26. Gluck JL, Myers JP, Pass LM: Cryptococcemia due to Cryptococcus albidus. South Med J 1987; 80: 511-513.
27. Lin SR, Peng CF, Yang SA, Yu HS: Isolation of Cryptococcus albidus var. albidus in patient with pemphigus foliaceus. Gaoxiong Yi Xue Ke Xue Za Zhi 1989; 5: 126-128.
28. Wells GM, Gajjar A, Pearson TA, Hale KL, Shenep JL: Brief report. Pulmonary cryptosporidiosis and Cryptococcus albidus fungemia in a child with acute lymphocytic leukemia. Med Pediatr Oncol 1998; 31: 544-546.
29. Ramchandren R, Gladstone DE: Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplant. Transplantation 2004; 77: 956.
30. Lee YA, Kim HJ, Lee TW, Kim MJ, Lee MH, Lee JH, Ihm CG: First report of Cryptococcus albidus-induced disseminated cryptococcosis in a renal transplant recipient. Korean J Intern Med 2004; 19: 53-57.
31. Krcmery V, Krupova I, Denning DW: Invasive yeast infections other than Candida spp. in acute leukaemia J Hosp Infect 1999; 41: 181-194.
32. Averbuch D, Boekhoutt T, Falk R, Engelhard D, Shapiro M, Block C, Polacheck I Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol 2002; 40: 479-484.
33. Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS: Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol 2001; 39: 1608-1611.
34. Kiertiburanakul S, Sungkanuparph S, Pracharktam R: Cryptococcus laurentii fungemia: a case report. J Infect Dis Antimicrob Agents 2001; 18: 112-114.
35. Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupl J, Kunova A, Stopkova-Grey K, Kukuckova E, Krupova I, Demitrovicova A, Kralovicova K: Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 1998; 41: 373-380.
36. Ikeda R, Sugita T, Shinoda T Serological relationships of Cryptococcus spp.: distribution of antigenic factors in Cryptococcus and intraspecies diversity. J Clin Microbiol 2000; 38: 4021-4025.
37. McCurdy LH, Morrow JD: Ventriculitis due to Cryptococcus uniguttulatus. South Med J 2001; 94: 65-66.
38. Rimek D, Haase G, Luck A, Casper J, Podbielski A: First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia. J Clin Microbiol 2004; 42: 481-483.
39. Dromer F, Moulignier A, Dupont B, Gueho E, Baudrimont M, Improvisi L, Provost F, Gonzalez-Canali G: Myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 1995; 9: 395-396.
40. Melo JC, Srinivasan S, Scott ML, Raff MJ: Cryptococcus albidus meningitis. J Infect 1980; 2: 79-82.
41. Simon G, Simon G, Erdos M, Marodi L: Invasive Cryptococcus laurentii disease in a nine-year-old boy with X-linked hyper-immunoglobulin M syndrome. Pediatr Infect Dis J 2005; 24: 935-937.
42. Manfredi R, Fulgaro C, Sabbatani S, Legnani G, Fasulo G: Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS. AIDS Patient Care STDS 2006; 20: 227-232.
43. Lindsberg PJ, Pieninkeroinen I, Valtonen M: Meningoencephalitis caused by Cryptococcus macerans. Scand J Infect Dis 1997; 29: 430-433.
44. Krumholz RA Pulmonary cryptococcosis. A case due to Cryptococcus albidus. Am Rev Respir Dis 1972; 105: 421-424.
45. Horowitz ID, Blumberg EA, Krevolin L: Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis. South Med J 1993; 86: 1070-1072.
46. Lynch JP 3rd, Schaberg DR, Kissner DG, Kauffman CA: Cryptococcus laurentii lung abscess. Am Rev Respir Dis 1981; 123: 135-138.
47. Miyagawa T, Hamagami S, Tanigawa N: Cryptococcus albidus-induced summer-type hypersensitivity pneumonitis. Am J Respir Crit Care Med 2000; 161: 961-966.
48. Narayan S, Batta K, Colloby P, Tan CY: Cutaneous cryptococcus infection due to C. albidus associated with Sezary syndrome. Br J Dermatol 2000; 143: 632-634.
49. Kamalam A, Yesudian P, Thambiah AS: Cutaneous infection by Cryptococcus laurentii. Br J Dermatol 1977; 97: 221-223.
50. Garelick JM, Khodabakhsh AJ, Lopez Y, Bamji M, Lister M: Scleral ulceration caused by Cryptococcus albidus in a patient with acquired immune deficiency syndrome. Cornea 2004; 23: 730-731.
51. de Castro LE, Sarraf OA, Lally JM, Sandoval HP, Solomon KD, Vroman DT: Cryptococcus albidus keratitis after corneal transplantation. Cornea 2005; 24: 882-883.
52. Custis PH, Haller JA, de Juan E Jr: An unusual case of cryptococcal endophthalmitis. Retina 1995; 15: 300-304.
53. Ritterband DC, Seedor JA, Shah MK, Waheed S, Schorr I: A unique case of Cryptococcus laurentii keratitis spread by a rigid gas permeable contact lens in a patient with onychomycosis. Cornea 1998; 17: 115-118.
54. Sinnott JT 4th, Rodnite J, Emmanuel PJ, Campos A: Cryptococcus laurentii infection complicating peritoneal dialysis. Pediatr Infect Dis J 1989; 8: 803-805.
55. Mocan H, Murphy AV, Beattie TJ, McAllister TA: Fungal peritonitis in children on continuous ambulatory peritoneal dialysis. Scott Med J 1989; 34: 494-496.
56. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE: Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30: 710-718.
57. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL: Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917-921.
58. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ: Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 2005; 43: 2163-2167.
59. van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD: Effects of voriconazole on Cryptococcus neoformans. Antimicrob Agents Chemother 2004; 48: 2014-2020.
60. Sabatelli EJ, Loebenberg D, Mendrick CA, Patel R, Norris C, McNicholas PM: In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against approximately 18,000 strains of clinically significant yeasts and mould. In: 44th Interscience Conference of Antimicrobial Agents and Chemotherapy, Washington, DC, USA 2004, p M-1810
61. Johnson MD, Perfect JR: Caspofungin: first approved agent in a new class of antifungals. Expert Opin Pharmacother 2003; 4: 807-823.
62. Denning DW Echinocandin: antifungal drugs. Lancet 2003; 362: 1142-1151.
63. Morrison VA: Echinocandin antifungals: review and update. Expert Rev Anti Infect Ther 2006; 4: 325-342.
64. Perfect JR, Cox GM: Drug resistance in Cryptococcus neoformans. Drug Resist Updat 1999; 2: 259-269.